TABLE 1.
Reagent | Target | Study models | Conclusions | References |
Deferoxamine (DFO) | Iron | Human cancer cells | DFO inhibited erastin-induced ROS accumulation and cell death | Dixon et al., 2012 |
Desferrioxamine (DFE) | Iron | Clinical patients | DFE slowed the clinical progression of the dementia associated with AD | Mclachlan et al., 1991 |
Clioquinol | Iron | Mouse model | Clioquinol prevented Tau deficiency impaired iron export | Lei et al., 2012 |
α-Lipoic acid (LA) | Iron | Mouse model | Effectively rescued tauopathy and cognitive impairment in P301S mice | Zhang Y. et al., 2018 |
Ferrostatin-1(Fer-1) Liproxstatin-1(Lip-1) | Lipid peroxidation | Primary neurons Mouse model | Fer-1/Lip-1 effectively ameliorate Aβ induced neuronal death and memory loss | Bao et al., 2021 |
Vitamin E | Lipid peroxidation | Clinical patients | Vitamin E slowed cognitive decline in patients with mild to moderate AD | Dysken et al., 2014 |
N-acetylcysteine (NAC) | Lipid peroxidation | Mouse model | Attenuated spatial memory deficits and synaptic plasticity loss in AD mice | More et al., 2018 |
Coenzyme Q10 (CoQ10) | Lipid peroxidation | Mouse model | Improved AD-Type behavioral and pathological symptoms in APP/PS1 mice | Muthukumaran et al., 2018 |
Selenium (Se) | Gpx4 | Mouse model | Improved cognitive impairment and AD -related pathological symptoms in mice | Zhang Z. et al., 2018 |